When I use a word . . . . Too much healthcare—Biomarkers
- 21 October 2022
- Vol. 379, o2533
- https://doi.org/10.1136/bmj.o2533
Abstract
The term “biomarker” is surprisingly new. The earliest instance is from 1973, when it was used to indicate the presence of material of biological origin.1 It continues to be used in this way in the geological and ecological literature. The earliest clinical use dates from 1977, in a paper on tumour biomarkers used in managing gynaecological malignancies.2 However, earlier references to such terms as “biochemical markers” (1949)3 and “biological markers” (1957)4 show that the concept has a longer pedigree.This publication has 14 references indexed in Scilit:
- An agenda for UK clinical pharmacology: Research priorities in biomarkers and surrogate end‐pointsBritish Journal of Clinical Pharmacology, 2012
- Biomarkers and Surrogate Endpoints in Monitoring Therapeutic InterventionsPublished by Wiley ,2008
- Biomarkers and surrogate endpointsBritish Journal of Clinical Pharmacology, 2005
- WHEN I USE A WORDBMJ, 1996
- Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression after Myocardial InfarctionThe New England Journal of Medicine, 1989
- Surrogate endpoints in clinical trials: Definition and operational criteriaStatistics in Medicine, 1989
- Surrogate endpoints in clinical trials: Cardiovascular diseasesStatistics in Medicine, 1989
- Beneficial and detrimental effects of therapy on immunity in breast cancerEndocrine, 1977
- A search for porphyrin biomarkers in nonesuch shale and extraterrestrial samplesOrigins of Life and Evolution of Biospheres, 1973
- Evidence Excluding Mutations, Polysomy, and Polyploidy as Possible Causes of Non-Mendelian Segregations in SaccharomycesAnnals of the Missouri Botanical Garden, 1949